Skip to main content
Caplight Logo









Aegle Therapeutics Corp

Aegle Therapeutics Corp

Private
Miami, FloridaHealthcare & Life Scienceshttps://aegletherapeutics.com/

Last Round

Seed Round

Aug 28, 2026

Total Funding Raised

$7.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Aegle Therapeutics Corp is a biotechnology company that develops a platform to isolate extracellular vesicles for treating burns and dermatological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

extracellular vesiclesEVregenerative therapyMSCmesenchymal stem cellcell-free therapybiopharmaceuticaldermatological disordersRDEBrecessive dystrophic epidermolysis bullosatissue regenerationbiotechclinical-stageexosome therapywound healing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aegle Therapeutics Corp Comparables

Compare Aegle Therapeutics Corp with similar companies based on industry and business-model similarity.

Aegle Therapeutics Corp comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xinnate AB
81%
Phoenicis Therapeutics
79%
INTENT Biologics
78%

Aegle Therapeutics Corp Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 28, 2026
Seed RoundMar 3, 2026
Convertible DebtDec 1, 2024
GrantOct 8, 2020

Aegle Therapeutics Corp Investors

Notable investors and investment history

Aegle Therapeutics Corp investors
InvestorRounds
Tellus BioVenturesGrant
DeepWork CapitalGrant
U.S. Department of WarGrant
Ocean Azul PartnersGrant
New World AngelsConvertible Debt, Grant
DEFTA PartnersGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    Raised $2.3M in Seed funding.

  • Aug 21, 2026

    Monthly visitors increased 52% MoM.

Aegle Therapeutics Corp Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aegle Therapeutics Corp Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aegle Therapeutics Corp's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range2
Year Founded2013
Last FundingAug 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?